LUCA Science, an Japanese developer of functional mitochondria as therapeutic agents, has raised $9.8 million in Series A financing. Axil Capital Partners led the round with participation from other investors that included Remiges Ventures, Nippon Venture Capital, Fast Track Initiative and CaHC.
Source: Press Release
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: